0.76 - 0.86
0.53 - 11.72
227.7K / 102.3K (Avg.)
-0.11 | -7.01
Analyze DCF forecasts for the company and compare them with competitors.
14.59K
Revenue has decreased from the previous period.
-71.77%
Revenue growth rate is unchanged from the previous period.
-8.75K
EBITDA has increased from the previous period.
-60.00%
EBITDA margin is unchanged from the previous period.
-8.75K
EBIT has increased from the previous period.
-60.00%
EBIT margin is unchanged from the previous period.
12.92K
Depreciation has decreased from the previous period.
14.59K
Total cash has decreased from the previous period.
100.00%
Cash percentage is unchanged from the previous period.
12.06K
Receivables have decreased from the previous period.
82.66%
Receivables percentage is unchanged from the previous period.
8.71K
Inventories have decreased from the previous period.
59.73%
Inventory percentage is unchanged from the previous period.
14.59K
Accounts payable has decreased from the previous period.
100.00%
Payables percentage is unchanged from the previous period.
-11.67K
Capital expenditure has decreased from the previous period.
-80.00%
CapEx percentage is unchanged from the previous period.
6.08%
WACC is unchanged from the previous period.
16.36%
Cost of equity is unchanged from the previous period.
3.71%
Cost of debt is unchanged from the previous period.
2.68
Beta is unchanged from the previous period.
15.93M
Diluted shares outstanding is unchanged from the previous period.
50.65M
Total debt is unchanged from the previous period.
11.73M
Total equity is unchanged from the previous period.
62.39M
Total capital is unchanged from the previous period.
81.19%
Debt weighting is unchanged from the previous period.
18.81%
Equity weighting is unchanged from the previous period.
-8.72K
EBIAT has increased from the previous period.
8.24K
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
4.64K
Terminal value is unchanged from the previous period.
-957.93K
Enterprise value is unchanged from the previous period.
-21.61M
Net debt is unchanged from the previous period.
20.65M
Equity value is unchanged from the previous period.
1.30
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
4.55B
The estimated revenue has increased from the previous period.
-2.73B
The estimated EBITDA has decreased from the previous period.
-1.32
The estimated EPS has decreased from the previous period.
-21.03M
The estimated net income has decreased from the previous period.
-2.73B
The estimated EBIT has decreased from the previous period.
39980.93B
The estimated SG&A expenses have increased from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$1.00
Analysts expect the stock price to increase by 29.03%.
Buy
Positive consensus among analysts.
